These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30974120)

  • 1. Population Pharmacokinetics of Doripenem in Pediatric Patients and Monte-Carlo Pharmacokinetic-Pharmacodynamic Simulations for Dosing Regimen Assessment.
    Matsuo Y; Ishibashi T; Matsumoto S; Katsube T; Wajima T
    J Pharm Sci; 2019 Sep; 108(9):3099-3105. PubMed ID: 30974120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Pharmacokinetics and Pharmacodynamics of Doripenem in Pediatric Patients.
    Matsuo Y; Ishibashi T; Shimamura K; Wajima T
    J Pharm Sci; 2015 Sep; 104(9):3194-8. PubMed ID: 25821174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modeling and simulation for dose rationale of doripenem in neonates and infants.
    Matsuo Y; Matsumoto S; Wajima T; Matsubara K
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):145-150. PubMed ID: 31969257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized Patients.
    Chung EK; Fleming MR; Cheatham SC; Kays MB
    Ann Pharmacother; 2017 Mar; 51(3):209-218. PubMed ID: 28168884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.
    Lee DH; Kim YK; Jin K; Kang MJ; Joo YD; Kim YW; Moon YS; Shin JG; Kiem S
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Lewis SJ; Kays MB; Mueller BA
    J Clin Pharmacol; 2016 Oct; 56(10):1277-87. PubMed ID: 26919659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Doripenem in Healthy Koreans and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients With Normal and Enhanced Renal Function.
    Kim SW; Choe S; Kim DJ; Zang DY; Lee DH
    Ther Drug Monit; 2018 Aug; 40(4):425-434. PubMed ID: 29746394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
    Samtani MN; Flamm R; Kaniga K; Nandy P
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2360-4. PubMed ID: 20385857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of efficacy of oral quinolone against Streptococcus pneumoniae AND Haemophilus influenzae with the use of Monte Carlo simulation].
    Mikamo H; Tanaka K; Watanabe K
    Jpn J Antibiot; 2006 Dec; 59(6):468-73. PubMed ID: 17334064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae.
    Noreddin AM; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2005 Aug; 26(2):120-5. PubMed ID: 16046101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment.
    Matsuo Y; Ishibashi T; Kubota R; Wajima T
    J Infect Chemother; 2015 Feb; 21(2):123-9. PubMed ID: 25487084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of doripenem in infected patients treated within and outside the intensive care unit.
    Bhalodi AA; Keel RA; Quintiliani R; Lodise TP; Nicolau DP; Kuti JL
    Ann Pharmacother; 2013 May; 47(5):617-27. PubMed ID: 23585647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by Gram-Positive Pathogens.
    Lodise TP; Bosso J; Kelly C; Williams PJ; Lane JR; Huang DB
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic modeling and pharmacodynamic assessment of cefozopran in pediatric patients.
    Ikawa K; Kozumi T; Ikeda K; Morikawa N; Kobayashi R
    Jpn J Antibiot; 2009 Oct; 62(5):435-44. PubMed ID: 20055120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics and pharmacodynamics of doripenem and meropenem in obese patients.
    Kays MB; Fleming MR; Cheatham SC; Chung EK; Juenke JM
    Ann Pharmacother; 2014 Feb; 48(2):178-86. PubMed ID: 24259653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection.
    Zhi LJ; Wang L; Chen XK; Zhai XY; Wen L; Dong L; Jacqz-Aigrain E; Shi ZR; Zhao W
    Drug Des Devel Ther; 2018; 12():855-862. PubMed ID: 29713143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
    Sumitani Y; Kobayashi Y
    Jpn J Antibiot; 2007 Dec; 60(6):394-403. PubMed ID: 18447209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia.
    Stein GE; Kulhanek G; Smith CL; Kuti JL; Nicolau DP; Scharmen A; Farnum C; Tran M; Kalra A; Havlichek DH
    Ann Pharmacother; 2012 Oct; 46(10):1281-6. PubMed ID: 23012385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically Based Pharmacokinetic Model for Predicting Omadacycline Pharmacokinetics and Pharmacodynamics in Healthy and Hepatic Impairment Populations.
    Zhang A; Sun Y; Zuo M; Wei H; Chen J; Zhao M; Yang W; Zhu L
    Clin Ther; 2024 Aug; 46(8):629-635. PubMed ID: 39069431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation.
    Yu W; Ji J; Xiao T; Ying C; Fang J; Shen P; Xiao Y
    Drug Des Devel Ther; 2017; 11():1951-1956. PubMed ID: 28721014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.